Literature DB >> 9620806

Atomic structure of progesterone complexed with its receptor.

S P Williams1, P B Sigler.   

Abstract

The physiological effects of progestins are mediated by the progesterone receptor, a member of the steroid/nuclear receptor superfamily. As progesterone is required for maintenance of pregnancy, its receptor has been a target for pharmaceuticals. Here we report the 1.8 A crystal structure of a progesterone-bound ligand-binding domain of the human progesterone receptor. The nature of this structure explains the receptor's selective affinity for progestins and establishes a common mode of recognition of 3-oxy steroids by the cognate receptors. Although the overall fold of the progesterone receptor is similar to that found in related receptors, the progesterone receptor has a quite different mode of dimerization. A hormone-induced stabilization of the carboxy-terminal secondary structure of the ligand-binding domain of the progesterone receptor accounts for the stereochemistry of this distinctive dimer, explains the receptor's characteristic pattern of ligand-dependent protease resistance and its loss of repression, and indicates how the anti-progestin RU486 might work in birth control. The structure also indicates that the analogous 3-keto-steroid receptors may have a similar mechanism of action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620806     DOI: 10.1038/30775

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  114 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Rational discovery of novel nuclear hormone receptor antagonists.

Authors:  M Schapira; B M Raaka; H H Samuels; R Abagyan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions.

Authors:  J W Thornton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

4.  Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.

Authors:  Xingtai Wang; Xiaofeng Qian; Hwai-Chen Guo; Jianming Hu
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  New variants of inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility.

Authors:  F T Wunderlich; H Wildner; K Rajewsky; F Edenhofer
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

6.  Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.

Authors:  P F Egea; A Mitschler; N Rochel; M Ruff; P Chambon; D Moras
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

7.  Molecular origins for the dominant negative function of human glucocorticoid receptor beta.

Authors:  Matthew R Yudt; Christine M Jewell; Rachelle J Bienstock; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  Folding and stability of the ligand-binding domain of the glucocorticoid receptor.

Authors:  Stephen H McLaughlin; Sophie E Jackson
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

9.  Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level.

Authors:  Yann Brelivet; Sabrina Kammerer; Natacha Rochel; Olivier Poch; Dino Moras
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

10.  Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation.

Authors:  Stefan Svensson; Tove Ostberg; Micael Jacobsson; Carina Norström; Karin Stefansson; Dan Hallén; Isabel Climent Johansson; Kristina Zachrisson; Derek Ogg; Lena Jendeberg
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.